Verified Service Provider in Angola
Molecular Diagnostics Labs in Angola
Engineering Excellence & Technical Support
Molecular Diagnostics Labs solutions for Clinical & Diagnostic Labs. High-standard technical execution following OEM protocols and local regulatory frameworks.
Advanced PCR & Gene Sequencing Capabilities
Empowering Angolan healthcare with state-of-the-art Polymerase Chain Reaction (PCR) and next-generation sequencing (NGS) technologies. We provide rapid, accurate detection of infectious diseases, genetic predispositions, and pathogen identification, crucial for public health initiatives and personalized medicine.
Comprehensive Molecular Assay Portfolio
Offering a wide range of validated molecular diagnostic assays covering infectious diseases (viral, bacterial, parasitic), oncology markers, and genetic disorders. Our lab is equipped to handle diverse diagnostic needs, contributing to improved patient outcomes and informed treatment decisions across Angola.
Robust Quality Assurance & Data Integrity
Adhering to stringent international quality standards and implementing rigorous quality control protocols. We ensure the reliability and reproducibility of all molecular diagnostic results, building trust and confidence in our services for healthcare providers and patients throughout Angola.
What Is Molecular Diagnostics Labs In Angola?
Molecular diagnostics laboratories in Angola are specialized facilities employing advanced techniques to analyze biological samples at the molecular level. This involves the detection and characterization of nucleic acids (DNA and RNA) and their associated proteins, providing highly specific and sensitive diagnostic information. The service is crucial for identifying the presence of pathogens, genetic predispositions, biomarkers for disease, and for monitoring therapeutic responses. These laboratories play a pivotal role in public health surveillance, personalized medicine, and infectious disease control within the Angolan context.
| Who Needs Molecular Diagnostics? | Typical Use Cases in Angola |
|---|---|
| Individuals presenting with symptoms suggestive of infectious diseases (e.g., malaria, tuberculosis, HIV, viral hepatitis, COVID-19). | Diagnosis and confirmation of endemic and epidemic infectious diseases. Monitoring of drug resistance in pathogens. |
| Patients undergoing treatment for chronic or infectious diseases. | Monitoring of viral load for HIV/AIDS treatment effectiveness. Assessing parasitic burden. |
| Individuals with suspected genetic disorders or inherited conditions. | Screening for inherited diseases. Genetic counseling and risk assessment. |
| Healthcare providers requiring precise etiological diagnosis for effective treatment planning. | Differentiating between bacterial and viral infections to guide antibiotic use. Identifying specific strains of pathogens for outbreak investigations. |
| Public health agencies involved in disease surveillance and control. | Early detection and tracking of infectious disease outbreaks. Monitoring the prevalence of specific pathogens in the population. |
| Blood banks and organ transplant centers for screening of donors. | Ensuring the safety of blood transfusions and organ transplants by detecting transfusion-transmissible infections. |
| Research institutions investigating disease pathogenesis and developing new diagnostic tools. | Facilitating research into local disease patterns and the development of context-specific diagnostic assays. |
Key Aspects of Molecular Diagnostics in Angola
- Targeted Detection: Identifying specific genetic sequences of pathogens (e.g., viruses, bacteria, parasites) or human genes associated with disease.
- Quantitative Analysis: Measuring the concentration of nucleic acids, such as viral load, to monitor disease progression or treatment efficacy.
- High Sensitivity and Specificity: Differentiating between closely related organisms or genetic variations, minimizing false positives and negatives.
- Rapid Turnaround Time: Enabling quicker diagnosis and initiation of appropriate treatment, particularly critical for infectious diseases.
- Application of Advanced Technologies: Utilization of techniques such as Polymerase Chain Reaction (PCR), Real-Time PCR (RT-PCR), sequencing, and microarrays.
Who Needs Molecular Diagnostics Labs In Angola?
The increasing demand for accurate and timely disease diagnosis, coupled with the growing burden of infectious and non-communicable diseases, highlights the critical need for advanced molecular diagnostics laboratories in Angola. These facilities offer a range of sophisticated tests that go beyond traditional methods, providing crucial information for effective patient management, disease surveillance, and public health initiatives. Molecular diagnostics enable the identification of pathogens at their genetic level, assess treatment efficacy, predict disease risk, and guide personalized medicine approaches. This advanced capability is essential for tackling prevalent health challenges in Angola and improving overall health outcomes.
| Target Customer/Department | Key Needs and Applications | Examples of Molecular Tests/Services |
|---|---|---|
| Hospitals (Infectious Disease Wards, Oncology, ICU, Pediatrics) | Rapid and accurate identification of infectious agents for targeted treatment; detection of drug resistance; cancer biomarker analysis; prenatal genetic screening. | PCR for viral/bacterial detection (e.g., HIV, TB, Malaria, COVID-19), Drug-resistant TB detection (e.g., Xpert MTB/RIF), HPV testing, Genetic sequencing for cancer profiling. |
| Public Health Institutions (National Reference Labs, Disease Surveillance Units) | Epidemiological surveillance of outbreaks; monitoring of disease prevalence and trends; identification of emerging pathogens; antimicrobial resistance surveillance. | Genotyping and subtyping of pathogens, whole-genome sequencing for outbreak investigation, molecular assays for sentinel surveillance programs. |
| Research Institutions and Universities (Medical Faculties, Biomedical Research Centers) | Basic and applied research; development of new diagnostic tools; training of future healthcare professionals in molecular techniques. | Various molecular biology techniques for research purposes, development of novel diagnostic assays, capacity building and training programs. |
| Clinical Laboratories (Independent and Hospital-based) | Expansion of testing menus; provision of specialized diagnostic services; improved turnaround times and accuracy for routine and specialized tests. | Wide range of PCR-based tests, serological assays with molecular confirmation, genotyping, molecular screening panels. |
| Government Ministries of Health (Policy and Planning Departments) | Informing public health policy; resource allocation for disease control programs; evaluation of intervention effectiveness; development of national health strategies. | Data from widespread molecular testing for informing national health priorities and resource allocation, impact assessment of public health interventions. |
| Non-Governmental Organizations (NGOs) in Health | Targeted diagnostic support for specific health programs (e.g., maternal and child health, HIV/AIDS, malaria); community-based screening and testing. | Point-of-care molecular diagnostics where applicable, specialized testing for program-specific diseases. |
| Pharmaceutical and Biotechnology Companies | Clinical trial support; pharmacogenomic testing; development and validation of new drugs and diagnostics. | Biomarker analysis for clinical trials, genetic testing for drug response prediction, quality control of diagnostic products. |
Target Customers and Departments for Molecular Diagnostics Labs in Angola
- Hospitals (Public and Private)
- Public Health Institutions
- Research Institutions and Universities
- Clinical Laboratories (Independent and Hospital-based)
- Government Ministries of Health
- Non-Governmental Organizations (NGOs) in Health
- Pharmaceutical and Biotechnology Companies (for clinical trials and research)
Molecular Diagnostics Labs Process In Angola
Molecular diagnostics labs in Angola follow a structured workflow to process patient samples and deliver accurate results. This process is critical for the timely diagnosis and management of infectious diseases, genetic disorders, and other health conditions. The workflow can be broadly divided into several key stages, starting from the initial patient inquiry or referral and culminating in the final report.
| Stage | Description | Key Activities | Potential Challenges in Angola | ||||
|---|---|---|---|---|---|---|---|
| Inquiry/Referral | The process begins when a healthcare provider or patient requests a molecular diagnostic test. | Understanding the specific test required, patient history, and sample type. Obtaining necessary pre-authorization if applicable. | Limited awareness of available molecular tests among some healthcare providers. Communication barriers. | ||||
| Sample Reception & Registration | Upon arrival at the lab, samples are received, checked for integrity, and registered in the laboratory information system (LIS). | Verification of sample labeling against requisition forms. Inspection for leaks, proper storage conditions. Assigning a unique laboratory identification number. Logging sample details (patient ID, test requested, collection date/time). | Inconsistent sample labeling. Lack of standardized collection protocols. Inadequate cold chain maintenance during transport. Limited access to or functionality of LIS. | ||||
| Sample Preparation & Nucleic Acid Extraction | The biological sample (e.g., blood, saliva, swab) is processed to isolate the DNA or RNA, which will be used for amplification. | Aliquotting samples. Cell lysis. DNA/RNA purification using kits or automated systems. Checking the quality and quantity of extracted nucleic acids. | Availability and cost of high-quality extraction kits. Power outages affecting automated extractors. Need for specialized reagents and consumables. Skilled personnel for manual extraction. | ||||
| Molecular Assay Setup & Amplification | The extracted nucleic acids are combined with primers, probes, enzymes, and buffers for amplification using techniques like PCR or isothermal amplification. | Pipetting reagents and nucleic acids into reaction vessels. Running the amplification instrument (e.g., real-time PCR machine). Monitoring amplification cycles. | Cost and availability of specialized reagents (enzymes, primers, probes). Availability and maintenance of PCR machines. Power fluctuations impacting thermal cycling. Need for strict contamination control. | Data Analysis & Interpretation | The amplification data is analyzed to detect the presence or absence of specific genetic material and quantify it if necessary. | Software-based analysis of amplification curves. Setting thresholds and baselines. Comparing results to positive and negative controls. Interpreting results in the context of clinical information. | Availability of sophisticated analysis software. Training for data analysts. Standardized interpretation guidelines. Need for access to reference databases for genetic variations. |
| Reporting & Result Delivery | A clear and concise report is generated, summarizing the findings and their clinical implications. This report is then communicated to the referring clinician. | Compiling raw data into a formal report. Including test methodology, results, and any necessary caveats. Secure transmission of results (electronic or hard copy). | Slow or unreliable communication channels. Limited access to secure electronic reporting systems. Need for clear, understandable language for clinicians not specializing in molecular diagnostics. | ||||
| Quality Control & Assurance | Throughout the entire process, rigorous QC measures are implemented to ensure the accuracy and reliability of the results. | Running positive and negative controls for each assay. Proficiency testing. Internal quality checks on reagents and equipment. Regular calibration of instruments. | Availability of reliable control materials. Consistent implementation of QC protocols. Limited access to external quality assessment schemes. Budgetary constraints for QC materials. | ||||
| Instrument Maintenance & Calibration | Regular maintenance and calibration of all molecular diagnostic equipment are essential for optimal performance. | Scheduled preventive maintenance. Performance verification. Calibration against standards. Troubleshooting equipment issues. | Lack of trained biomedical engineers for specialized equipment repair. Difficulty in sourcing spare parts. Limited access to calibration standards. High cost of maintenance contracts. | ||||
| Inventory Management & Reagent Ordering | Efficient management of reagents, consumables, and supplies is crucial to avoid stockouts and ensure continuous operation. | Tracking inventory levels. Forecasting needs. Placing orders with suppliers. Proper storage of temperature-sensitive reagents. | Delays in customs clearance and importation of reagents. Fluctuations in international currency affecting procurement costs. Limited supplier options. Poor storage infrastructure (e.g., unreliable cold storage). | ||||
| Biosafety & Waste Management | Strict adherence to biosafety protocols and proper disposal of hazardous waste are paramount to protect laboratory personnel and the environment. | Implementing universal precautions. Using appropriate personal protective equipment (PPE). Decontamination procedures. Segregation and disposal of biohazardous waste according to regulations. | Inadequate infrastructure for biosafety (e.g., fume hoods, autoclaves). Lack of proper waste disposal facilities and transportation. Limited training on biosafety best practices. Insufficient supply of PPE. | ||||
| Training & Professional Development | Ensuring that laboratory personnel are adequately trained and continuously update their skills is vital for maintaining high-quality services. | On-the-job training. Formal training courses. Attending workshops and conferences. Staying updated with new technologies and methodologies. | Limited availability of specialized training programs within Angola. High cost of external training. Brain drain of skilled personnel. Need for government or donor support for professional development. |
Molecular Diagnostics Lab Process in Angola: Workflow Stages
- Sample Reception and Registration
- Sample Preparation and Nucleic Acid Extraction
- Molecular Assay Setup and Amplification
- Data Analysis and Interpretation
- Reporting and Result Delivery
- Quality Control and Assurance
- Instrument Maintenance and Calibration
- Inventory Management and Reagent Ordering
- Biosafety and Waste Management
- Training and Professional Development
Molecular Diagnostics Labs Cost In Angola
The cost of molecular diagnostics in Angola can vary significantly depending on several factors. These laboratories play a crucial role in identifying diseases at a molecular level, offering high accuracy and specificity for a range of conditions. Understanding the pricing structure is essential for individuals and healthcare providers seeking these advanced diagnostic services.
| Type of Molecular Test (Examples) | Estimated Price Range (Angolan Kwanza - AOA) | Notes |
|---|---|---|
| Viral Load Testing (e.g., HIV, Hepatitis B/C) | 25,000 - 60,000 AOA | Commonly performed, relatively standardized. |
| Pathogen Detection (e.g., Malaria, Tuberculosis - GeneXpert) | 20,000 - 45,000 AOA | Cost influenced by specific pathogen and assay. |
| Basic Genetic Testing (e.g., single gene disorders) | 50,000 - 150,000 AOA | Can vary based on the number of genes analyzed. |
| Cancer Biomarker Testing (e.g., EGFR mutation in lung cancer) | 70,000 - 200,000 AOA | Often involves more complex panels and specialized reagents. |
| Comprehensive Infectious Disease Panels (e.g., respiratory panels) | 80,000 - 250,000 AOA | Tests for multiple pathogens simultaneously. |
| Next-Generation Sequencing (NGS) - Targeted Panels | 150,000 - 500,000+ AOA | Higher end due to advanced technology and extensive data analysis. |
| NGS - Whole Exome/Genome Sequencing | 500,000 - 2,000,000+ AOA | Most comprehensive and costly, typically for rare or complex genetic conditions. |
Key Pricing Factors for Molecular Diagnostics in Angola
- Type of Test: The complexity and target of the molecular test are primary drivers of cost. Tests for common pathogens (like malaria or certain viruses) are generally less expensive than those for rare genetic disorders, specific cancer markers, or complex infectious disease panels.
- Technology Used: Different molecular diagnostic platforms employ varying levels of technology, automation, and reagent sophistication. Real-time PCR (qPCR) is a common method, but Next-Generation Sequencing (NGS) or other advanced techniques will inherently be more costly due to equipment, specialized reagents, and data analysis requirements.
- Reagent and Consumable Costs: The quality and brand of reagents and consumables used in the molecular assays directly impact pricing. High-purity reagents and specialized kits contribute to higher operational costs.
- Laboratory Overhead and Expertise: The operating expenses of a molecular diagnostics lab, including highly trained personnel (molecular biologists, geneticists, technicians), specialized equipment maintenance, laboratory space, and quality control measures, are factored into the pricing. Laboratories in major urban centers might have higher overheads.
- Accreditation and Quality Standards: Labs adhering to international accreditation standards (e.g., ISO 15189) often invest more in their processes and quality assurance, which can be reflected in their pricing. Higher quality assurance generally translates to more reliable results.
- Volume and Bulk Testing: For larger healthcare institutions or public health programs requiring high volumes of specific tests, there might be opportunities for volume-based discounts.
- Importation Costs: Many specialized reagents and equipment used in molecular diagnostics are imported into Angola. Import duties, taxes, and transportation costs add to the overall price.
- Location within Angola: While major cities like Luanda will have more established laboratories, costs in more remote regions might be influenced by logistical challenges and limited access to specialized services.
- Urgency of Results: Some labs may offer expedited turnaround times for an additional fee.
Affordable Molecular Diagnostics Labs Options
Affordable molecular diagnostics labs are crucial for widespread access to critical health information. This section explores options that prioritize cost-effectiveness without compromising on accuracy or speed. We'll delve into the concept of value bundles, which combine multiple services for a reduced price, and outline various cost-saving strategies employed by these labs.
| Value Bundle | Included Tests/Services | Potential Cost Savings | Target Audience |
|---|---|---|---|
| Comprehensive Respiratory Panel | Influenza A/B, RSV, COVID-19, Adenovirus, Parainfluenza | 15-25% discount compared to individual tests | General practitioners, urgent care centers, public health initiatives |
| Sexually Transmitted Infection (STI) Multiplex Panel | Chlamydia, Gonorrhea, Trichomonas, Mycoplasma genitalium | 10-20% discount compared to individual tests | Sexual health clinics, reproductive health centers, large healthcare networks |
| Gastrointestinal Pathogen Panel (GPP) | Salmonella, Shigella, Campylobacter, E. coli O157:H7, Norovirus | 12-22% discount compared to individual tests | Hospitals, infectious disease departments, public health agencies |
| Antimicrobial Resistance (AMR) Screening Bundle | Common resistance genes for key bacterial pathogens (e.g., MRSA, VRE) | Customizable pricing, often with a 5-15% discount on combined gene panels | Hospitals focusing on infection control, specialized laboratories |
| Basic Genetic Health Screening | Common pharmacogenomic markers, carrier screening for select genetic disorders | 20-30% discount compared to individual genetic tests | Primary care physicians, individuals seeking proactive health management |
Key Features of Affordable Molecular Diagnostics Labs
- Focus on high-volume testing to leverage economies of scale.
- Streamlined operational workflows to minimize overhead.
- Utilization of advanced automation and robotics.
- Partnerships with reagent suppliers for bulk purchasing.
- Transparent pricing models with clear breakdown of costs.
- Investment in efficient diagnostic platforms and technologies.
Verified Providers In Angola
Navigating the healthcare landscape in Angola can be a complex task. Ensuring you are receiving care from verified and reputable providers is paramount for your well-being. Franance Health stands out as a premier choice for a multitude of reasons, underpinned by their stringent credentialing process and unwavering commitment to quality healthcare. This document outlines why Franance Health's verified providers represent the best choice for your medical needs in Angola.
| Key Verification Criteria | Franance Health's Commitment |
|---|---|
| Medical Licensure and Registration | Mandatory verification of all current and valid medical licenses and registrations with relevant Angolan authorities. |
| Educational Background and Specialization | Thorough review of academic credentials, medical school diplomas, and specialized training certifications. |
| Professional Experience and Reputation | Assessment of past professional experience, peer reviews, and a clean disciplinary record. |
| Ethical Practice and Patient Care Standards | Evaluation of adherence to medical ethics, patient rights, and established quality of care protocols. |
| Facility Accreditation (for institutions) | Verification of hospital and clinic accreditations and compliance with national health regulations. |
Why Choose Franance Health Verified Providers in Angola?
- Uncompromising Quality Assurance: Franance Health implements a rigorous vetting process for all its affiliated healthcare professionals and facilities. This includes verifying medical licenses, educational qualifications, professional certifications, and a proven track record of patient care. This ensures that you are treated by competent and experienced individuals.
- Access to a Comprehensive Network: Franance Health boasts a wide network of doctors, specialists, hospitals, and clinics across Angola. This extensive reach means you are likely to find the right provider for your specific medical condition, regardless of your location or the complexity of your needs.
- Patient-Centric Approach: Beyond technical qualifications, Franance Health prioritizes providers who demonstrate a strong commitment to patient satisfaction and ethical medical practice. This includes effective communication, empathy, and a focus on personalized treatment plans.
- Streamlined Access to Care: By choosing a Franance Health verified provider, you often benefit from a more streamlined experience. This can include easier appointment scheduling, clear communication regarding services and costs, and a generally smoother patient journey.
- Enhanced Trust and Reliability: The 'verified' status from Franance Health acts as a significant trust signal. It assures you that a third party has diligently assessed and confirmed the credentials of the healthcare provider, offering peace of mind in your healthcare decisions.
- Commitment to Continuous Improvement: Franance Health actively monitors the performance and feedback of its network. This dedication to continuous improvement ensures that their affiliated providers consistently meet high standards of care and adapt to evolving medical practices.
Scope Of Work For Molecular Diagnostics Labs
This document outlines the scope of work for molecular diagnostics laboratories, detailing essential technical deliverables and standard specifications required for their operation. It covers key areas from sample processing to data analysis and reporting, ensuring high-quality and reliable diagnostic services.
| Area | Technical Deliverables | Standard Specifications |
|---|---|---|
| Sample Reception and Processing | Receipt of biological samples (e.g., blood, saliva, tissue, swabs), verification of sample integrity and labeling, accessioning into Laboratory Information Management System (LIMS). | Adherence to Good Laboratory Practices (GLP), documented sample handling SOPs, proper cold chain management for transport and storage, patient identifier matching with request forms. |
| Nucleic Acid Extraction and Purification | Isolation of DNA or RNA from various sample types using automated or manual methods, quality assessment of extracted nucleic acids. | Validated extraction kits and protocols, minimum nucleic acid yield and purity (e.g., A260/A280 ratio), documented extraction efficiency for different sample matrices. |
| Amplification and Detection Methods | Application of validated molecular amplification techniques (e.g., PCR, RT-PCR, isothermal amplification) and detection platforms (e.g., real-time fluorescence, gel electrophoresis, sequencing). | Validated primer/probe sets, specific amplification efficiency, sensitivity (limit of detection - LoD), specificity (absence of cross-reactivity), established analytical and clinical validation data for each assay. |
| Data Acquisition and Analysis | Automated acquisition of raw data from detection instruments, quantitative or qualitative analysis of results, interpretation of findings based on assay validation. | Validated software for data analysis, defined cut-off values for positive/negative results, robust algorithms for interpretation, audit trails for all analytical steps. |
| Quality Control and Assurance | Implementation of internal and external quality control (IQC, EQAS) procedures, proficiency testing participation, lot-to-lot consistency checks for reagents. | Positive and negative controls for every run, internal controls (e.g., internal target, inhibition control), adherence to CLIA, ISO 15189, or relevant accreditation standards, documented QC procedures and corrective actions. |
| Reporting and Data Management | Generation of accurate and timely diagnostic reports, secure storage of patient data and results, compliance with data privacy regulations. | Clear and concise report format, inclusion of patient information, test performed, results, interpretation, and relevant commentary. LIMS system with secure data backup and retrieval capabilities, HIPAA/GDPR compliance. |
| Instrument Maintenance and Calibration | Routine preventative maintenance, performance verification, and calibration of all molecular diagnostic instruments. | Manufacturer-recommended maintenance schedules, documented maintenance logs, calibration records traceable to national or international standards, performance monitoring for critical parameters. |
| Reagent and Consumable Management | Procurement, inventory management, storage, and quality assessment of reagents and consumables. | Approved supplier list, expiry date tracking, appropriate storage conditions (e.g., -20°C, -80°C, room temperature), lot traceability, certificates of analysis for critical reagents. |
| Personnel Training and Competency | Onboarding and ongoing training of laboratory personnel, competency assessment for all critical procedures. | Documented training programs, competency assessments conducted at regular intervals (e.g., annually), records of training and competency evaluation, qualified and certified personnel. |
Key Areas of Scope of Work
- Sample Reception and Processing
- Nucleic Acid Extraction and Purification
- Amplification and Detection Methods
- Data Acquisition and Analysis
- Quality Control and Assurance
- Reporting and Data Management
- Instrument Maintenance and Calibration
- Reagent and Consumable Management
- Personnel Training and Competency
Service Level Agreement For Molecular Diagnostics Labs
This Service Level Agreement (SLA) outlines the performance expectations and guarantees for molecular diagnostic laboratory services provided by [Your Lab Name] to [Client Name]. This SLA specifically addresses response times for sample processing and reporting, as well as uptime guarantees for critical systems and services.
| Service Component | Standard Response Time Target | Guarantee/Uptime | Remedies for Failure |
|---|---|---|---|
| Sample Processing (Standard Tests) | Within 3 business days of Sample Receipt Time | 98% of all standard tests processed within TAT | For each instance of failure, a 10% discount on the affected test fee, or a credit for future services equivalent to the test fee (client's choice). |
| Sample Processing (High-Priority/STAT Tests) | Within 24 business hours of Sample Receipt Time | 99% of all STAT tests processed within TAT | For each instance of failure, a 25% discount on the affected test fee, or a credit for future services equivalent to the test fee (client's choice). |
| Report Issuance (Standard Tests) | Within 1 business day of completed processing | 98% of all standard reports issued within TAT | For each instance of failure, a 5% discount on the affected test fee, or a credit for future services equivalent to 50% of the test fee (client's choice). |
| Report Issuance (High-Priority/STAT Tests) | Within 4 business hours of completed processing | 99% of all STAT reports issued within TAT | For each instance of failure, a 15% discount on the affected test fee, or a credit for future services equivalent to the test fee (client's choice). |
| Critical System Uptime (LIMS, Reporting Portal) | N/A | 99.5% uptime, excluding Scheduled Maintenance | For every cumulative hour of unscheduled Critical System Downtime exceeding 0.5% per month, a credit equivalent to 0.1% of the monthly service fee for the affected services. |
| Instrument Availability (Core PCR/Sequencing Platforms) | N/A | 98% availability for planned testing schedules, excluding Scheduled Maintenance | For each day an instrument is unavailable beyond this guarantee and impacts a client's testing schedule, a credit equivalent to 5% of the daily anticipated service fees related to that instrument. |
Key Definitions
- Sample Receipt Time: The time at which a sample, meeting all submission requirements, is physically received at the [Your Lab Name] facility.
- Turnaround Time (TAT): The duration from Sample Receipt Time until the validated and approved report is issued to the client.
- Critical System Downtime: Any period where a service essential for core laboratory operations (e.g., LIMS, PCR instruments, reporting portal) is unavailable and prevents the processing or reporting of results.
- Scheduled Maintenance: Pre-announced periods where systems may be unavailable for updates or maintenance, and are excluded from uptime calculations.
- Force Majeure: Events beyond the reasonable control of [Your Lab Name] that prevent performance, including but not limited to natural disasters, pandemics, acts of war, or widespread power outages.
In-Depth Guidance
Frequently Asked Questions
Phase 02: Execution
Ready when you are
Let's scope your Molecular Diagnostics Labs in Angola project in Angola.
OEM Approved
54Regions
Scaling healthcare logistics and technical systems across the entire continent.